Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SAVA Cassava Sciences Inc
- Stocks
- Healthcare
- NASDAQ: SAVA
Price (delayed)
$2.09
Market cap
$100.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.53
Enterprise value
-$16.36M
Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to
Highlights
Cassava Sciences's equity has soared by 62% YoY but it has decreased by 12% from the previous quarter
The net income has plunged by 199% from the previous quarter and by 52% YoY
Cassava Sciences's EPS has plunged by 189% from the previous quarter and by 32% YoY
Key stats
What are the main financial stats of SAVA
Market
Valuations
Earnings
Shares outstanding
48.31M
Market cap
$100.96M
Enterprise value
-$16.36M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.79
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$146.1M
Net income
-$72.79M
EBIT
-$72.79M
EBITDA
-$71.75M
Free cash flow
-$109.24M
Per share
Balance sheet
Liquidity
EPS
-$1.53
EPS diluted
-$1.51
Free cash flow per share
-$2.26
Book value per share
$2.64
Revenue per share
$0
TBVPS
$2.92
Total assets
$140.93M
Total liabilities
$13.32M
Debt
$0
Equity
$127.62M
Working capital
$106.91M
Debt to equity
0
Current ratio
9.08
Quick ratio
8.86
Net debt/EBITDA
1.64
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-38%
Return on equity
-46.3%
Return on invested capital
N/A
Return on capital employed
-57%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SAVA stock price
How has the Cassava Sciences stock price performed over time
Intraday
1.95%
1 week
18.08%
1 month
49.29%
1 year
-90.31%
YTD
-11.44%
QTD
39.33%
Financial performance
How have Cassava Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$146.1M
Net income
-$72.79M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 199% from the previous quarter and by 52% YoY
Cassava Sciences's operating income has decreased by 47% YoY and by 3.3% from the previous quarter
Price vs fundamentals
How does SAVA's price correlate with its fundamentals
Growth
What is Cassava Sciences's growth rate over time
Valuation
What is Cassava Sciences stock price valuation
P/E
N/A
P/B
0.79
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Cassava Sciences's EPS has plunged by 189% from the previous quarter and by 32% YoY
SAVA's P/B is 87% below its 5-year quarterly average of 6.2 and 75% below its last 4 quarters average of 3.2
Cassava Sciences's equity has soared by 62% YoY but it has decreased by 12% from the previous quarter
Efficiency
How efficient is Cassava Sciences business performance
SAVA's return on equity has dropped by 176% since the previous quarter and by 33% year-on-year
Cassava Sciences's ROA has decreased by 34% YoY
Dividends
What is SAVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SAVA.
Financial health
How did Cassava Sciences financials performed over time
SAVA's total liabilities has plunged by 83% YoY but it is up by 13% from the previous quarter
The current ratio has contracted by 22% from the previous quarter
Cassava Sciences's debt is 100% less than its equity
Cassava Sciences's equity has soared by 62% YoY but it has decreased by 12% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.